StockAxis

Tarsons Products Ltd

Quarterly Result - Q1F23

Tarsons Products Ltd

Plastic Products

Current

CMP
Rs. 855.30
Rating:
Hold
August 06, 2022

Previous

Rating:
Hold

Stock Info

BSE
543399
NSE
TARSONS
Bloomberg
TARSONS:IN
Reuters
Sector
Plastic Products
Face Value (Rs)
2
Equity Capital (Rs cr)
36
Mkt Cap (Rs cr)
3985.42
52w H/L (Rs)
924.90 - 538.70
Avg Daily Vol (BSE+NSE)
86,369

Shareholding Pattern

(as on 30-Jun)
%
Promoter
37.01
FIIs
26.82
DIIs
14.58
Public & Others
21.59
Source: Ace equity, StockAxis Research

Price performance

Return (%)
1m
3m
12m
Absolute
10.20
23.29
-
Sensex
9.89
4.82
7.15
Source: Ace equity, StockAxis Research

Indexed Stock Performance

Tarsons Products Ltd Sensex
Tarsons Products Ltd
Source: Ace equity, StockAxis Research

Quarterly Result Highlights

Tarsons posted revenue of INR69cr (down 1% YoY and 19% QoQ), mainly due to a decline in domestic business with the erosion of Covid business and normalisation of conventional business. Gross margin contracted 290 bps YoY to 79.1% on higher input cost due to geo-political tension and supply chain disruption as well as an adverse change in product mix. However, margin improved 140 bps sequentially. EBITDA at INR31cr (down 15% YoY and 30% QoQ)

EBITDA margin shrank 780 bps YoY and 680 bps QoQ to 45.4%, mainly due to higher employee cost as a result of employee addition to support future growth (up 100 bps YoY) and higher other expense due to increased travel and participation in fairs and exhibitions (up 390 bps YoY). PAT stood at INR20cr down 18% YoY and 31% QoQ.

Concall highlights

  • Tarsons is registering steady demand for all its product categories and has been receiving enquiries for its products across industries.
  • Tarsons intends to commence the manufacturing of new products PCR and cell culture in its new facilities, which are witnessing increased demand in the domestic as well as export markets.
  • Company has imposed price hikes for FY23, implemented with a quarter’s lag. Customers usually accept price hikes after 45–60 days; hence, the total effect will be visible for the remaining nine months of FY23.
  • Company is strengthening the senior management team in various areas of sales, production and other important functions, which has led to increased employee cost.
  • The export market size is INR50,000cr; Tarsons aims to gain market share and thereby grow export revenue.
  • The industry has been receiving significant investor attention and is expected to see more investments in future.
  • Tarsons has meticulously laid down plans and strategies for future growth and is well positioned to face intensifying competition in the domestic and international markets.
  • EBITDA guidance of mid-to-high 40’s has been maintained.
  • Specialised resin prices have been stabilised, whereas packaging and paper costs have started declining.
  • Capex
    • Expansion of the new facilities is on track at Panchla and Amta.
    • Out of the total envisaged capex of INR500cr, Tarsons has incurred INR250cr; INR28cr of this amount was spent in Q1FY23.
  • The planned capex is as follows:-
    • Panchla:- INR250cr
    • Amta:- INR100cr
    • Existing facilities:- INR150cr

Outlook & valuation

Tarsons has built a recognized brand in the domestic market with strong market share of 9-12% in India. The company is well placed to capture the growth arising from shift from glassware to plastic ware, growth for end users and, continued gains for domestic manufacturers among others. There is a respectable import market for the company to capture and also a huge export opportunity arising from the “China plus one” strategy. The stock is currently trading at 36.8x FY25E EPS.

Quarterly Financials

Particulars (Rs. in Crores) Q1FY23 Q1FY22 YoY Q4FY22 QoQ FY22 FY21 Y-o-Y
Revenue from Operations 68.63 69.15 -0.75% 84.94 -19.20% 300.79 228.91 31.40%
COGS 14.35 12.44 18.98 62.90 61.51
Gross Profit 54.28 56.71 -4.29% 65.96 -17.71% 237.89 167.41 42.10%
Gross Margin (%) 79.09% 82.01% 77.65% 79.09% 73.13%
Employee Benefit Expenses 8.26 7.62 8.60 31.41 24.44
Other Expenses 14.88 12.33 13.02 53.79 39.53
EBITDA 31.14 36.76 -15.30% 44.34 -29.77% 152.70 103.44 47.62%
EBITDA Margin (%) 45.37% 53.16% 52.20% 50.77% 45.19%
Depreciation 6.14 4.57 7.24 21.96 13.66
EBIT 25.00 32.20 -22.35% 37.10 -32.61% 130.74 89.78 45.63%
EBIT Margin (%) 36.43% 46.56% 43.68% 43.46% 39.22%
Finance Cost 0.43 0.83 0.45 4.22 2.72
Oher Income 2.69 1.98 2.58 8.47 5.38
Profit Before Exceptional Items & Tax 27.26 33.34 39.22 134.99 92.43
Profit Before Tax 27.26 33.34 -18.23% 39.22 -30.49% 134.99 92.43 46.04%
Tax 6.95 8.51 9.76 34.33 23.56
Effective Tax Rate (%) 25.50% 25.51% 24.89% 25.43% 25.49%
Profit After Tax 20.31 24.84 -18.22% 29.46 -31.07% 100.66 68.87 46.17%
PAT Margin (%) 29.59% 35.91% 34.69% 33.47% 30.09%
Earnings Per Share (Rs.) 3.82 4.88 -21.72% 5.69 -32.86% 19.46 13.43 44.90%

Source: Company Filings; StockAxis Research

Consolidated Financial statements

Profit & Loss statement

Yr End March (Rs Cr) 2019 2020 2021 2022 2023E 2024E 2025E
Net Sales 178.70 175.90 228.90 300.80 320.00 355.00 405.00
Expenditure
Material Cost 61.70 57.90 72.70 62.90 91.20 95.90 112.20
Employee Cost 16.10 20.10 24.40 31.40 33.20 45.00 46.00
Other Expenses 29.30 28.70 28.30 53.20 41.30 40.50 46.20
EBITDA 71.70 69.30 103.40 153.20 154.30 173.70 200.60
EBITDA Margin 40.10% 39.40% 45.20% 50.90% 48.20% 48.90% 50.00%
Depreciation & Amortization 14.60 14.20 13.70 22.00 31.00 40.00 45.00
EBIT 57.10 55.10 89.80 131.30 123.30 133.70 165.60
EBIT Margin % 31.90% 31.30% 39.20% 43.60% 38.50% 37.70% 40.90%
Other Income 6.00 4.20 5.40 8.50 8.00 10.00 10.00
Interest & Finance Charges 7.20 6.10 2.70 4.20 3.00 2.00 2.00
Profit Before Tax - Before Exceptional 55.80 53.10 92.40 135.50 128.30 141.70 163.60
Profit Before Tax 55.80 53.10 92.40 135.50 128.30 141.70 164.60
Tax Expense 16.90 12.60 23.60 34.50 33.10 35.70 41.20
Effective Tax rate 30.20% 23.70% 25.50% 25.40% 25.80% 25.20% 25.00%
Net Profit 39.00 40.50 68.90 101.10 95.20 106.00 123.40
Net Profit Margin 21.80% 23.00% 30.10% 33.60% 29.80% 29.90% 30.00%

Balance Sheet

Yr End March (Rs Cr) 2019 2020 2021 2022 2023E 2024E 2025E
Share Capital 0.20 0.20 0.20 10.60 10.60 10.60 10.60
Total Reserves 135.10 197.40 244.10 479.20 567.70 666.30 781.20
Shareholders' Funds 135.30 197.60 244.30 489.80 578.40 677.00 791.80
Non Current Liabilities
Long Term Burrowing 18.70 5.90 3.30 9.30 20.30 30.30 42.30
Deferred Tax Assets / Liabilities 3.90 3.20 3.30 4.40 4.40 4.40 4.40
Current Liabilities -
Short Term Borrowings 36.30 18.80 23.10 12.30 12.30 12.30 12.30
Trade Payables 2.00 5.90 6.00 13.00 6.00 15.70 9.40
Other Current Liabilities 13.50 14.70 11.20 8.20 8.20 8.20 8.20
Short Term Provisions 2.20 1.10 1.50 1.50 1.50 1.50 1.50
Total Equity & Liabilities 212.00 248.70 296.00 544.20 636.80 755.10 875.60
Assets -
Net Block 89.00 92.00 120.40 188.50 407.50 467.50 572.50
Non Current Investments - - - - - - -
Long Term Loans & Advances 18.80 17.50 40.40 8.40 8.40 8.40 8.40
Current Assets
Currents Investments - - - - - - -
Inventories 46.40 48.70 46.70 82.40 51.00 97.10 70.80
Sundry Debtors 44.60 38.20 47.00 65.20 45.10 67.50 61.40
Cash and Bank 0.90 26.30 3.10 85.80 11.10 1.00 50.80
Short Term Loans and Advances 3.50 4.80 9.80 0.10 0.10 0.10 0.10
Total Assets 212.00 248.70 296.00 544.20 636.70 755.00 875.60

Cash Flow Statement

Yr End March (Rs Cr) 2019 2020 2021 2022 2023E 2024E 2025E
Profit After Tax 39.00 40.50 68.90 101.10 95.20 106.00 123.40
Depreciation 14.60 14.20 13.70 22.00 31.00 40.00 45.00
Changes in Working Capital -8.80 6.40 -16.00 -46.80 44.50 -58.70 27.00
Cash From Operating Activities 51.30 64.20 68.20 76.20 170.70 87.30 196.40
Purchase of Fixed Assets -33.90 -26.00 -61.90 -90.00 -250.00 -100.00 -150.00
Free Cash Flows 17.40 38.20 6.30 -13.80 -79.30 -12.70 46.40
Cash Flow from Investing Activities -33.60 -25.40 -63.90 -90.00 -250.00 -100.00 -150.00
Increase / (Decrease) in Loan Funds -29.50 -11.40 -6.80 -11.80 11.00 10.00 11.00
Equity Dividend Paid - - - -7.10 -6.70 -7.40 -8.60
Cash from Financing Activities -18.20 -13.80 -27.20 -18.90 13.40 2.60 3.40
Net Cash Inflow / Outflow -0.50 25.00 -23.00 -32.70 -65.90 -10.10 49.90
Opening Cash & Cash Equivalents 1.00 0.50 25.30 2.30 174.10 230.60 1.00
Closing Cash & Cash Equivalent 0.50 25.30 2.30 174.10 230.60 317.00 50.80

Key Ratios

Yr End March 2019 2020 2021 2022 2023E 2024E 2025E
Basic EPS 2029.10 2026.60 13.50 19.00 17.90 19.90 23.20
Diluted EPS 2029.10 2026.60 13.50 19.00 17.90 19.90 23.20
Cash EPS (Rs) 2787.60 2735.10 16.20 23.10 23.70 27.40 31.50
DPS - - - 1.30 1.30 1.40 1.60
Book value (Rs/share) 7045.50 9878.50 48.00 92.10 108.70 127.20 148.80
ROCE (%) Post Tax 46.30% 21.90% 28.80% 26.60% 17.40% 16.20% 16.00%
ROE (%) 28.80% 20.50% 28.20% 20.60% 16.50% 16.90% 17.00%
Inventory Days 47.00 99.00 76.00 78.00 76.00 76.00 76.00
Receivable Days 46.00 86.00 68.00 68.00 63.00 58.00 58.00
Payable Days 2.00 8.00 9.00 11.00 11.00 11.00 11.00
PE - - 57.70 36.30 47.70 42.90 36.80
P/BV - - 16.30 7.50 7.90 6.70 5.70
EV/EBITDA 0.90 0.10 38.70 23.50 29.60 26.40 22.70
Dividend Yield (%) - - 0.00% 0.20% 0.10% 0.20% 0.20%
P/Sales - - 17.40 12.20 14.20 12.80 11.20
Net debt/Equity 0.50 0.00 0.10 - 0.00 0.10 0.00
Net Debt/ EBITDA 0.90 0.10 0.30 -0.40 0.10 0.20 0.00
Sales/Net FA (x) 4.00 1.90 2.20 1.90 1.10 0.80 0.80